Oxford Bioscience Partners IV LP

This profile gathers the share dealings of Oxford Bioscience Partners IV LP across 3 companies, led by Trubion Pharmaceuticals, Inc, Cyberkinetics Neurotechnology Systems, Inc. and Solexa, Inc. The record holds 8 filings, for trades running from 18 January 2006 to 23 October 2006.

No open-market sale appears; the market trades are 4 purchases worth €1.2M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

A typical purchase (the median) is worth €218k.

The latest filing, published on 25 October 2006, reports a transaction in Trubion Pharmaceuticals, Inc. The most recent open-market purchase was published on 20 October 2006, 7,324 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.